Mxi1 and mxi1-0 antagonize N-myc function and independently mediate apoptosis in neuroblastoma

David A Erichsen1, Michael B Armstrong2, Daniel S Wechsler3

  • 1Section of Pediatric Hematology-Oncology, Department of Pediatrics and Communicable Diseases, The University of Michigan School of Medicine, Ann Arbor, MI, USA.

Translational Oncology
|March 10, 2015
PubMed

Insights

Mxi1 and its Mxi1-0 isoform antagonize MYCN in neuroblastoma cells, preventing apoptosis in low serum conditions. Their amino-terminal domains are crucial for this MYCN antagonism and independently influence cell survival pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Neuroblastoma (NB) is a common childhood cancer with poor outcomes in advanced stages, particularly with MYCN gene amplification.
  • Mxi1 protein antagonizes N-Myc activity by inhibiting its binding to Max and E-boxes, leading to transcriptional repression and suppressed cell proliferation.
  • Mxi1 and its alternatively transcribed isoform, Mxi1-0, share critical DNA and Max binding domains but differ in N-terminal sequences.

Purpose of the Study:

  • To investigate whether Mxi1-0 antagonizes N-Myc activity in neuroblastoma cells, similar to Mxi1.
  • To determine the role of Mxi1 and Mxi1-0 in regulating MYCN-driven apoptosis and cell proliferation in neuroblastoma.
  • To identify the specific domains of Mxi1 and Mxi1-0 responsible for MYCN antagonism.

Main Methods:

  • Transient transfection of SHEP NB cells and MYCN-transfected SHEP/MYCN cells with vectors encoding full-length Mxi1, Mxi1-0, or the Mxi exon 2-6 domain.
  • Incubation of transfected cells in low and normal serum conditions.
  • Assessment of cell numbers, apoptosis via activated caspase-3 staining and DNA fragmentation ELISA, and proliferation rates.

Main Results:

  • MYCN-amplified neuroblastoma cells undergo apoptosis in low serum, but Mxi1 or Mxi1-0 transfection prevents this.
  • Mxi1 and Mxi1-0 restore normal proliferation rates in MYCN-transfected cells under normal serum conditions.
  • The amino-terminal domains of Mxi1 and Mxi1-0 are essential for MYCN antagonism, as the Mxi exon 2-6 domain alone had no effect.
  • Mxi1 and Mxi1-0 induce apoptosis via the caspase-8 extrinsic pathway, whereas N-Myc utilizes the caspase-9 intrinsic pathway.

Conclusions:

  • Mxi1 and Mxi1-0 effectively antagonize N-Myc in neuroblastoma cells, impacting cell survival.
  • The N-terminal regions of Mxi1 and Mxi1-0 are critical for their anti-MYCN activity.
  • Mxi1 and Mxi1-0 possess independent mechanisms for inducing apoptosis, distinct from their interaction with N-Myc.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K